CMHDF (China Resources Medical Holdings Co) Cash-to-Debt: 1.25 (As of Jun. 2026) — 53% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CMHDF China Resources Medical Holdings Co Ltd CMHDF
91 GF Score
Price $0.58
GF Value $0.95
! 5 Warning Signs
View Full Analysis

What is China Resources Medical Holdings Co Cash-to-Debt?

China Resources Medical Holdings Co CMHDF 91 Cash-to-Debt is 1.25 as of Jun. 2026, which is 53% below its 10-year median of 2.67. GuruFocus rates CMHDF with a GF Score™ of 91/100 and a GF Value™ of $0.95. The stock has 5 warning signs investors should review. Among 673 Healthcare Providers & Services companies, China Resources Medical Holdings Co ranks better than 56.46% on this metric.

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. China Resources Medical Holdings Co's cash to debt ratio for the quarter that ended in Jun. 2026 was 1.25.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, China Resources Medical Holdings Co could pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.

The historical rank and industry rank for China Resources Medical Holdings Co's Cash-to-Debt or its related term are showing as below:

CMHDF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.54   Med: 2.67   Max: No Debt
Current: 1.1

During the past 13 years, China Resources Medical Holdings Co's highest Cash to Debt Ratio was No Debt. The lowest was 0.54. And the median was 2.67.

CMHDF's Cash-to-Debt is ranked better than
56.46% of 673 companies
in the Healthcare Providers & Services industry
Industry Median: 0.78 vs CMHDF: 1.10

China Resources Medical Holdings Co  (OTCPK:CMHDF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


China Resources Medical Holdings Co Cash-to-Debt Related Terms


China Resources Medical Holdings Co Cash-to-Debt Historical Data

* Premium members only.

The historical data trend for China Resources Medical Holdings Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

China Resources Medical Holdings Co Cash-to-Debt Chart

China Resources Medical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.53 1.43 0.55 0.66 1.21

China Resources Medical Holdings Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.66 0.87 1.21 1.25

CMHDF vs HCA, THC, EHC: Cash-to-Debt Comparison

For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resources Medical Holdings Co Cash-to-Debt vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where China Resources Medical Holdings Co's Cash-to-Debt falls into.


CMHDF
91GF Score
China Resources Medical Holdings Co Ltd CMHDF
Cash-to-Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China Resources Medical Holdings Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

China Resources Medical Holdings Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2025 is calculated as:

China Resources Medical Holdings Co's Cash to Debt Ratio for the quarter that ended in Jun. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash-to-Debt →
What does a Cash-to-Debt of 1.25 mean?
China Resources Medical Holdings Co (CMHDF) has a Cash-to-Debt of 1.25 as of Jun. 2026. This is 53% below median its historical median of 2.67. Over the past decade, China Resources Medical Holdings Co's Cash-to-Debt has ranged from 0.54 to 10,000.00. According to the industry distribution chart, China Resources Medical Holdings Co ranks #293 out of 673 companies in the Healthcare Providers & Services industry, placing it in the top 43.5%.
Is China Resources Medical Holdings Co's Cash-to-Debt too high?
China Resources Medical Holdings Co's current Cash-to-Debt of 1.25 is 53% below median its 10-year median of 2.67. Over the past 10 years, this metric has ranged from a low of 0.54 to a high of 10,000.00. The Healthcare Providers & Services industry median Cash-to-Debt is 0.78. China Resources Medical Holdings Co's value of 1.25 is 60.3% above this industry median. Based on the distribution chart, China Resources Medical Holdings Co ranks #293 out of 673 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, China Resources Medical Holdings Co has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's Cash-to-Debt compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, China Resources Medical Holdings Co ranks #293 out of 673 companies for Cash-to-Debt. This puts China Resources Medical Holdings Co in the upper half of its industry. The industry median Cash-to-Debt is 0.78. China Resources Medical Holdings Co's value of 1.25 is 60.3% above this benchmark. Historically, China Resources Medical Holdings Co's own Cash-to-Debt has ranged from 0.54 to 10,000.00 over the past decade. While the company's 10-year median is 2.67 vs. the industry median of 0.78, China Resources Medical Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Healthcare Providers & Services company?
The median Cash-to-Debt among Healthcare Providers & Services companies is 0.78, based on 673 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Medical Holdings Co's current Cash-to-Debt of 1.25 is 60.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median Cash-to-Debt is 0.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Medical Holdings Co's current Cash-to-Debt is 1.25, which is 53% below median its own 10-year median of 2.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current Cash-to-Debt of 1.25. The stock's GF Value™ is $0.95, compared to a current price of $0.58 — trading 38.9% below its estimated fair value. The current Cash-to-Debt is 1.25, which is 53% below median its 10-year median of 2.67 and 60.3% above the Healthcare Providers & Services industry median of 0.78. China Resources Medical Holdings Co's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current Cash-to-Debt is 1.25 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?

Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued. The current stock price of $0.58 is trading 38.9% below its estimated GF Value™ of $0.95.

Key valuation signals for CMHDF:

  • Cash-to-Debt: 1.25 (53% below median its 10-year median of 2.67)
  • GF Value™: $0.95 vs. price of $0.58 (38.9% below fair value)
  • GF Score™: 91/100 with 5 warning signs
  • Industry Position: 60.3% above the Healthcare Providers & Services median (#293 of 673)

No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


China Resources Medical Holdings Co Business Description

Other Exchanges 01515:Hong Kong1PH:Germany
Address No. 9, Fuyi Street, 14th Floor, Kunlun Center Office Building, Fengtai District, Beijing, CHN, 100069
China Resources Medical Holdings Company Limited is a healthcare group operating in mainland China. Through its Hospital Business segment, it owns and operates general hospitals that provide outpatient and inpatient medical services, generating the majority of its revenue from patient fees. Its Other Business segment offers hospital management and operation services, supply chain services covering the sale of pharmaceuticals, medical devices and consumables, and other ancillary services to participating hospitals and IOT/OT hospitals. The company serves patients, government and partner hospitals, and healthcare institutions across various provinces in China. It is part of the state-owned China Resources Group, which provides backing and integration with a broader healthcare platform. Revenue is derived primarily from medical service fees at self-owned hospitals, supplemented by management fees and supply chain sales to affiliated hospitals.
91GF Score

Get the complete analysis for CMHDF

Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.58
Price
$0.95
GF Value